- 12,073
- 14,888
- Joined
- Jul 27, 2013
XBiotech Identifies “Super Bloods” for the Development of a True Human™ COVID-19 Therapy | XBiotech
Donors with Potent Natural Immunity Against the Virus are Identified as the Starting Point for XBiotech’s Drug Development Program to Treat COVID-19 AUSTIN, Texas , May 01, 2020 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) announced today that human immune donors have now been identified that
investors.xbiotech.com
XBiotech announces that it has identified human immune donors that can support the development of a True Human antibody therapy for COVID-19.
The donors, screened at South Texas Blood & Tissue Center, have high titers of COVID-19 antibodies and do not have a history of serious illness from the coronavirus.
The company is now receiving the blood samples and has begun the discovery process to isolate the genetic information responsible for producing the strong antibody responses